223 related articles for article (PubMed ID: 35885036)
1. Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Matsoukas JM; Gadanec LK; Zulli A; Apostolopoulos V; Kelaidonis K; Ligielli I; Moschovou K; Georgiou N; Plotas P; Chasapis CT; Moore G; Ridgway H; Mavromoustakos T
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885036
[TBL] [Abstract][Full Text] [Related]
2. Diminazene aceturate uses different pathways to induce relaxation in healthy and atherogenic blood vessels.
Kate Gadanec L; Qaradakhi T; Renee McSweeney K; Matsoukas JM; Apostolopoulos V; Burrell LM; Zulli A
Biochem Pharmacol; 2023 Feb; 208():115397. PubMed ID: 36566945
[TBL] [Abstract][Full Text] [Related]
3. The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
Qaradakhi T; Gadanec LK; McSweeney KR; Tacey A; Apostolopoulos V; Levinger I; Rimarova K; Egom EE; Rodrigo L; Kruzliak P; Kubatka P; Zulli A
Clin Exp Pharmacol Physiol; 2020 May; 47(5):751-758. PubMed ID: 31901211
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.
Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B
J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037
[TBL] [Abstract][Full Text] [Related]
6. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.
Santos ES; Silva PC; Sousa PSA; Aquino CC; Pacheco G; Teixeira LFLS; Araujo AR; Sousa FBM; Barros RO; Ramos RM; Rocha JA; Nicolau LAD; Medeiros JVR
Chem Biol Interact; 2022 Nov; 367():110161. PubMed ID: 36116513
[TBL] [Abstract][Full Text] [Related]
7. The ACE2 activator diminazene aceturate ameliorates colitis by repairing the gut-vascular barrier in mice.
Zhang C; Cao X; Wang H; Li Z; Zhang Y
Microvasc Res; 2023 Jul; 148():104544. PubMed ID: 37127063
[TBL] [Abstract][Full Text] [Related]
8. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
[TBL] [Abstract][Full Text] [Related]
9. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2 activator, DIZE in the basolateral amygdala attenuates the tachycardic response to acute stress by modulating glutamatergic tone.
Silva CC; Correa AMB; Kushmerick C; Sharma NM; Patel KP; de Almeida JFQ; Moreira FA; Ferreira AJ; Fontes MAP
Neuropeptides; 2020 Oct; 83():102076. PubMed ID: 32800589
[TBL] [Abstract][Full Text] [Related]
11. Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by γ-irradiation through boosting ACE2 signaling cascade.
Hasan HF; Elgazzar EM; Mostafa DM
Life Sci; 2020 Jul; 253():117749. PubMed ID: 32380079
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
[TBL] [Abstract][Full Text] [Related]
13. Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
Fraga-Silva RA; Costa-Fraga FP; Montecucco F; Sturny M; Faye Y; Mach F; Pelli G; Shenoy V; da Silva RF; Raizada MK; Santos RA; Stergiopulos N
J Sex Med; 2015 Feb; 12(2):289-302. PubMed ID: 25411084
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
[TBL] [Abstract][Full Text] [Related]
15. ACE2 Attenuates Epithelial-Mesenchymal Transition in MLE-12 Cells Induced by Silica.
Li S; Li Y; Xu H; Wei Z; Yang Y; Jin F; Zhang M; Wang C; Song W; Huo J; Zhao J; Yang X; Yang F
Drug Des Devel Ther; 2020; 14():1547-1559. PubMed ID: 32368013
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation.
Velkoska E; Patel SK; Burrell LM
Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):384-95. PubMed ID: 27367913
[TBL] [Abstract][Full Text] [Related]
17. Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications.
Esfahani SH; Jayaraman S; Karamyan VT
J Pharmacol Exp Ther; 2022 Nov; 383(2):149-156. PubMed ID: 36507848
[TBL] [Abstract][Full Text] [Related]
18. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model.
Dhawale VS; Amara VR; Karpe PA; Malek V; Patel D; Tikoo K
Toxicol Appl Pharmacol; 2016 Sep; 306():17-26. PubMed ID: 27343405
[TBL] [Abstract][Full Text] [Related]
19. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784
[TBL] [Abstract][Full Text] [Related]
20. Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model.
Lu Z; Wu D; Wang Z; Zhang H; Du Y; Wang G
BMC Pharmacol Toxicol; 2022 Jul; 23(1):44. PubMed ID: 35787308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
